Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Occupational Diseases D009784 42 associated lipids
Hypotension D007022 41 associated lipids
Adenoma D000236 40 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Heart Failure D006333 36 associated lipids
Epilepsy D004827 35 associated lipids
Hyperplasia D006965 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Hyperinsulinism D006946 27 associated lipids
Alcoholism D000437 27 associated lipids
Myocardial Infarction D009203 21 associated lipids
Anemia D000740 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypocalcemia D006996 12 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Dehydration D003681 11 associated lipids
Iron Overload D019190 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Hepatitis D006505 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Hearing Disorders D006311 10 associated lipids
Myocardial Stunning D017682 10 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Leprosy D007918 8 associated lipids
Jaundice, Neonatal D007567 7 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Thrombophlebitis D013924 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Testicular Neoplasms D013736 5 associated lipids
Glucosephosphate Dehydrogenase Deficiency D005955 5 associated lipids
Osteomalacia D010018 5 associated lipids
Biliary Tract Diseases D001660 3 associated lipids
Addison Disease D000224 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Anemia, Refractory D000753 3 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Carcinogenesis D063646 3 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Gilbert Disease D005878 2 associated lipids
Fasciitis D005208 2 associated lipids
Telangiectasia, Hereditary Hemorrhagic D013683 1 associated lipids
Hemosiderosis D006486 1 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Neurocysticercosis D020019 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Gulick AM et al. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. 2000 Biochemistry pmid:10769114
Tian B et al. Predicting enzyme-substrate specificity with QM/MM methods: a case study of the stereospecificity of (D)-glucarate dehydratase. 2013 Biochemistry pmid:23901785
Tiwari P et al. Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. 2016 Biochimie pmid:26655363
Ferioli A et al. Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers. 1989 Jul-Sep Biol Trace Elem Res pmid:2484601
Singh J and Gupta KP Calcium glucarate prevents tumor formation in mouse skin. 2003 Biomed. Environ. Sci. pmid:12747003
Fujii Y et al. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). 2000 Biomed. Pharmacother. pmid:10759292
Conner TA et al. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose. 2012 Biometals pmid:22706571
Pai AB et al. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. 2011 Biometals pmid:21229380
Shiue E et al. Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. 2015 Biotechnol. Bioeng. pmid:25258165
Adzharov D et al. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats]. 1989 Biull Eksp Biol Med pmid:2914170
Ageeva TA and ShkurupiÄ­ VA [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate]. 1994 Biull Eksp Biol Med pmid:7522618
Bhandal N and Russell R Intravenous versus oral iron therapy for postpartum anaemia. 2006 BJOG pmid:17004982
Perelló MF et al. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. 2014 BJOG pmid:24423186
WHITE LP et al. The immediate hematologic effects of intravenous saccharated iron oxide. 1952 Blood pmid:14953947
HOLLY RG Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology. 1951 Blood pmid:14869375
Breymann C Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. 2002 Nov-Dec Blood Cells Mol. Dis. pmid:12547241
Price E et al. A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. 2014 Blood Cells Mol. Dis. pmid:25065855
Eiselt J et al. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. 2006 Blood Purif. pmid:17077626
Breborowicz A et al. Intravenous iron sucrose changes the intraperitoneal homeostasis. 2009 Blood Purif. pmid:19325240
Li H and Wang SX Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 Blood Purif. pmid:18212498
Gemici C et al. Is there any role of intravenous iron for the treatment of anemia in cancer? 2016 BMC Cancer pmid:27542823
Iversen C et al. The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. 2007 BMC Evol. Biol. pmid:17439656
Rodionov DA et al. Genomic encyclopedia of sugar utilization pathways in the Shewanella genus. 2010 BMC Genomics pmid:20836887
Dong T and Schellhorn HE Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. 2009 BMC Genomics pmid:19650909
Vindal V et al. GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. 2007 BMC Genomics pmid:17714599
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145
Di Nocera PP et al. Genome organization of epidemic Acinetobacter baumannii strains. 2011 BMC Microbiol. pmid:21985032
Barraclough KA et al. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). 2009 BMC Nephrol pmid:19635169
Manley HJ and Grabe DW Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study. 2004 BMC Nephrol pmid:14718064
Pollak VE et al. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. 2009 BMC Nephrol pmid:19245700
Shimizu Y et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. 2009 Bone pmid:19555782
Spencer-Peet J et al. Urinary d-glucaric acid excretion and serum gamma-glutamyl transpeptidase activity in alcoholism. 1975 Br J Addict Alcohol Other Drugs pmid:2272
Muñoz M et al. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. 2012 Br J Anaesth pmid:22337966
Basora M et al. Optimizing preoperative haemoglobin with intravenous iron. 2013 Br J Anaesth pmid:23404979
Bisbe E et al. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. 2011 Br J Anaesth pmid:21841061
Tokola O et al. Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. 1975 Br J Clin Pharmacol pmid:786355
Labadarios D et al. The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. 1978 Br J Clin Pharmacol pmid:23138
Park BK Assessment of the drug metabolism capacity of the liver. 1982 Br J Clin Pharmacol pmid:6128018
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
Fuchs W et al. Lansoprazole does not affect the bioavailability of oral contraceptives. 1994 Br J Clin Pharmacol pmid:7833230
Heinemeyer G et al. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. 1986 Br J Clin Pharmacol pmid:2868749
Németh I and Szeleczki T Enhanced drug metabolism and renal dysfunction. 1981 Br J Clin Pharmacol pmid:7213515
Ylikallio A and Sotaniemi EA Drug metabolism and liver function after methyldopa withdrawal. 1980 Br J Clin Pharmacol pmid:7426273
Perucca E et al. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. 1980 Br J Clin Pharmacol pmid:7437261
Makki KA et al. Overnight urine specimens for the determination of D-glucaric acid excretion in man. 1979 Br J Clin Pharmacol pmid:486295
Perucca E et al. The comparative enzyme-inducing properties of antiepileptic drugs [proceedings]. 1979 Br J Clin Pharmacol pmid:444364
Oxley J et al. Lack of hepatic enzyme inducing effect of sodium valproate. 1979 Br J Clin Pharmacol pmid:385027
Barot MH et al. Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy. 1978 Br J Clin Pharmacol pmid:687505
Stevens PM et al. Urinary D-glucaric acid and oral contraceptives. 1978 Br J Clin Pharmacol pmid:656297
Henry DA et al. The [14C]-aminopyrine breath test. A comparison of different forms of analysis. 1979 Br J Clin Pharmacol pmid:533576